Macular disease treatment PBS listed

Macular Disease Foundation Australia today applauded the Federal Government’s decision to place the registered drug ranibizumab (Lucentis) on the PBS, enabling patients affordable access to this sight saving treatment for Diabetic Macular Edema and Retinal Vein Occlusion. The Foundation has been advocating strongly for access and affordability for registered treatment for these serious macular diseases,